Be thorough, and do not hesitate to ask the provider to walk through your specific risk factors with you
The result could position the drug as a treatment for MASH, which currently only has one FDA approved treatment in the market, Madrigals resmetirom (rezdiffra) , which achieves resolution of MASH and improves fibrosis, but does not have the added benefits of weight loss and glycemic control
Compound GLP-1 Branded GLP-1 Agonists like Ozempic, Saxenda, and Wegovy are rigorously tested and approved by regulatory bodies such as the U.S
Jensen, Michael D., Ryan, D
92,96,100,103 In addition, it is also efficacious in the treatment of solid tumors, such as breast cancer, 102,104 lung cancer, 97,103,105 glioma, 103,106 prostate cancer, 107 kidney cancer, 108 bladder cancer, 109 colon cancer, 110 and hepatocellular carcinoma